CoveConnectTM is a proprietary end-to-end analytic platform for brain imaging data designed to derive precision biomarkers to accelerate and de-risk clinical trials. Cove’s software solution is multimodal, disease-agnostic, and AI-powered, combining advanced neuroscience tools and machine learning to efficiently process, analyze, and interpret data from MRIs, MEGs, and EEGs.
Our team performs ongoing enhancements to model and software services, ensuring they stay current, adaptive, and responsive to evolving user needs and technological advancements.
Our models are built on data from hundreds of patients across motor, mood, and memory disorders, leading to robust functional connectivity metrics and applicability to a wide range of neurologic and psychiatric disorders.
Our platform enables enhanced processing, analysis, and data interpretation, accelerating R&D in the neurosciences.
Our model uses artificial intelligence to maximize the accuracy and precision of predictions based on the input brain data.
"CoveConnectTM is essential for pharmaceuticals, academic institutions, and medical device companies studying the effects of pharmaceutical agents or other interventions on the human brain. Clients are using CoveConnectTM to identify disease-related endpoints for clinical trials or characterize subpopulations in heterozygous patient groups."
We provide efficient software solutions to address common challenges with processing, analyzing, and interpreting brain data science, with a focus on neurophysiologic recordings. This service offers combined neuroscientific and data science expertise to accelerate and de-risk neuroscience research and development.
We partner with organizations to develop software technologies to accelerate neuroscience research. These strategic and synergistic collaborations support the implementation of precision neuroscience and neuromodulation in the clinical trial setting.
